Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05257083 |
|---|---|
| Brief Title: | A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma (CARTITUDE-6) |
| First Submitted : | February 16, 2022 |
| First Submitted that Met QC Criteria : | February 16, 2022 |
| First Posted : | February 25, 2022 |
| Last Update Submitted that Met QC Criteria : | May 14, 2024 |
| Last Update Posted : | May 16, 2024 |